within Pharmacolibrary.Drugs.ATC.V;

model V08CA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00026000000000000003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00013000000000000002,
    k12             = 0.13,
    k21             = 0.13
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V08CA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gadopentetic acid (also known as gadopentetate dimeglumine or Gd-DTPA) is a gadolinium-based contrast agent primarily used in magnetic resonance imaging (MRI) to enhance the quality of images. It is approved for clinical use and remains widely used today for diagnostic imaging of various body tissues and organs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single intravenous bolus injection.</p><h4>References</h4><ol><li><p>Schwope, RB, et al., &amp; Margolis, DJ (2015). Gadoxetic acid: pearls and pitfalls. <i>Abdominal imaging</i> 40(6) 2012–2029. DOI:<a href=\"https://doi.org/10.1007/s00261-015-0354-7\">10.1007/s00261-015-0354-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25613332/\">https://pubmed.ncbi.nlm.nih.gov/25613332</a></p></li><li><p>Hylton, NM (2000). Suspension of breast-feeding following gadopentetate dimeglumine administration. <i>Radiology</i> 216(2) 325–326. DOI:<a href=\"https://doi.org/10.1148/radiology.216.2.r00au55325\">10.1148/radiology.216.2.r00au55325</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10924547/\">https://pubmed.ncbi.nlm.nih.gov/10924547</a></p></li><li><p>Le Mignon, MM, et al., &amp; Bonnemain, B (1990). Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers. <i>Investigative radiology</i> 25(8) 933–937. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2394577/\">https://pubmed.ncbi.nlm.nih.gov/2394577</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V08CA01;
